Europe — EMA
Olmesartan/Amlodipine Sandoz (Olmesartan Medoxomil, Amlodipine)
GNH USA supplies Olmesartan/Amlodipine Sandoz (Olmesatran), a hypertension drug class for high blood pressure management. Request a quote for global supply.
Request sourcing
What is Olmesartan Medoxomil, Amlodipine?
Olmesartan medoxil, the active ingredient in Olmesartan/Amlodipine Sandoz, is an angiotensin II receptor blocker presented as a fixed‑dose combination tablet for oral use. It treats hypertension, often in patients who require additional blood pressure control beyond monotherapy. GNH USA supplies Olmesartan/Amlodipine Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Olmesartan/Amlodipine Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Olmesartan Medoxomil, Amlodipine used for?
Olmesartan/Amlodipine Sandoz is indicated for the management of high blood pressure within the renin‑angiotensin‑aldosterone system pathway. - Hypertension: provides additive blood pressure reduction when monotherapy is insufficient. - Isolated systolic hypertension in the elderly: helps achieve target systolic pressures. - Hypertensive patients with concomitant calcium‑channel blocker need: offers convenient single‑pill therapy. - Patients requiring renin‑angiotensin blockade plus vasodilation: combines two mechanisms for better control.
What are the side effects of Olmesartan Medoxomil, Amlodipine?
Side effects reported with the combination reflect the profile of each component.
Common Side Effects: - Peripheral edema: swelling of ankles or feet. - Headache: mild to moderate intensity. - Dizziness or light‑headedness: especially after standing. - Flushing: transient warmth sensation. - Fatigue: general tiredness. - Cough: rare, may be related to the ARB component.
Serious or Rare Side Effects: - Angio‑edema: rapid swelling of lips, tongue or airway. - Severe hypotension: symptomatic low blood pressure. - Hepatic dysfunction: elevated liver enzymes. - Myocardial infarction: rare but reported. - Hyperkalemia: elevated potassium levels. - Acute kidney injury: sudden decline in renal function.
What precautions apply to Olmesartan Medoxomil, Amlodipine?
When prescribing Olmesartan/Amlodipine Sandoz, clinicians should consider several safety aspects. - Pregnancy: contraindicated due to risk of fetal toxicity. - Renal impairment: monitor kidney function and adjust therapy as needed. - Hepatic disease: use with caution; liver function should be assessed. - Electrolyte imbalance: watch for hyperkalemia, especially with concomitant potassium‑sparing agents. - Orthostatic hypotension: advise patients to rise slowly. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.
What does Olmesartan Medoxomil, Amlodipine interact with?
Olmesartan/Amlodipine Sandoz may interact with several drug classes.
Major Interactions (Avoid): - Dual renin‑angiotensin system blockade: combining with ACE inhibitors or other ARBs can increase risk of renal dysfunction and hyperkalemia. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise amlodipine levels, leading to excessive hypotension.
Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can blunt antihypertensive effect and affect renal function. - Diuretics: may potentiate hypotensive response; monitor blood pressure. - Potassium‑rich supplements or salts: increase risk of hyperkalemia. - Lithium: may increase serum lithium concentrations. - Alcohol: additive blood‑pressure‑lowering effect; advise moderation.



